JetBlue Airways Corp
JBLU
$0.00
-0.66%
JetBlue Airways Corp is a low-cost airline operating in the Airlines, Airports & Air Services industry. It positions itself as a carrier offering high-quality service, including assigned seating and in-flight entertainment, across approximately 100 destinations primarily in the Americas.…
JBLU
JetBlue Airways Corp
$0.00
Investment Opinion: Should I buy JBLU Today?
Based on a synthesis of the data, the objective assessment for JBLU is Hold. The stock's deeply discounted valuation (P/S of 0.185) and analyst projections for a return to profitability ($1.52 EPS) prevent a Sell rating, as they offer speculative upside. However, the severe balance sheet stress, persistent operational losses, and high near-term uncertainty make it unsuitable for a Buy recommendation. Only investors with a very high risk tolerance and a long-term view should consider a position, and even then, it should be a small, speculative portion of a portfolio.
Sign up to view all
JBLU 12-Month Price Forecast
The outlook is bifurcated between a deep-value opportunity and a value trap. The probability-weighted scenario suggests limited near-term upside with significant downside risk, warranting a neutral stance. Confidence is medium due to the high volatility of underlying assumptions (fuel, execution).
Wall Street consensus
Most Wall Street analysts maintain a constructive view on JetBlue Airways Corp's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
7 analysts
Implied Upside
—
vs. current price
Analyst Count
7
covering this stock
Price Range
$0 - $0
Analyst target range
No sufficient analyst coverage available. The provided data includes institutional rating actions but does not contain consensus target price or ratings distribution figures required for a summary of Wall Street analyst consensus.
Bulls vs Bears: JBLU Investment Factors
JetBlue presents a classic high-risk, high-potential-reward scenario. The stock is deeply undervalued on a sales basis and analysts project a return to profitability, which could catalyze a significant re-rating. However, this is counterbalanced by severe financial distress, consistent losses, and substantial operational risks that threaten its viability.
Bullish
- Extremely Low Valuation: P/S ratio of 0.185 suggests the market is pricing in deep pessimism, offering a potential margin of safety.
- Strong Revenue Base: Analysts forecast FY revenue of ~$13.6B, indicating underlying business scale and demand.
- Recent Price Near 52-Week Low: Current price of $4.42 is close to the 52-week low of $3.34, limiting near-term downside.
- Positive Analyst EPS Outlook: Consensus forecasts positive EPS of $1.52 for the coming year, signaling expected profitability recovery.
Bearish
- Persistent Financial Losses: Q4 2025 net loss of $177M and negative net margin of -7.9% show ongoing profitability challenges.
- Severe Balance Sheet Stress: Debt-to-equity of 4.84 and negative free cash flow of -$1.02B TTM indicate high financial risk.
- Poor Capital Efficiency: Negative ROE of -28.4% and ROA of -1.27% reflect ineffective use of shareholder funds.
- Operational and Macro Headwinds: News highlights risks from oil price spikes, TSA staffing crises, and recent operational breakdowns.
JBLU Technical Analysis
The stock's overall trend over the last six months has been volatile, with a significant rally from around $4.40 in early October to a peak near $6.46 in mid-February, followed by a sharp decline to the current price of $4.42. The 1-month performance shows a severe drop of 20.22%, significantly underperforming the S&P 500, which fell 5.25% in the same period. Over the last 3 months, the stock is down 2.86%, slightly outperforming the broader market's 4.63% decline. The current price of $4.42 sits near the lower end of its 52-week range of $3.34 to $6.50, indicating the stock is under significant pressure and closer to its yearly low than its high.
Beta
1.75
1.75x market volatility
Max Drawdown
-47.5%
Largest decline past year
52-Week Range
$3-$7
Price range past year
Annual Return
-10.3%
Cumulative gain past year
| Period | JBLU Return | S&P 500 |
|---|---|---|
| 1m | -11.7% | -4.3% |
| 3m | -1.5% | -4.0% |
| 6m | -6.4% | -2.0% |
| 1y | -10.3% | +22.2% |
| ytd | -1.5% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JBLU Fundamental Analysis
Revenue in the latest quarter (Q4 2025) was $2.24 billion, representing a year-over-year decline of 1.45%. The company continues to face profitability challenges, with a net loss of $177 million in Q4 2025, translating to a net margin of -7.9%. Financial health is a concern, highlighted by a high debt-to-equity ratio of 4.84 and negative free cash flow of $1.02 billion over the trailing twelve months. Operational efficiency metrics are weak, with a negative Return on Equity (ROE) of -28.4% and a negative Return on Assets (ROA) of -1.27%, indicating poor utilization of shareholder capital and company assets.
Quarterly Revenue
$2.2B
2025-12
Revenue YoY Growth
-0.01%
YoY Comparison
Gross Margin
+0.45%
Latest Quarter
Free Cash Flow
$-1.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JBLU Overvalued?
Given the company's negative net income, the trailing P/E ratio of -2.79 is not meaningful. Therefore, the Price-to-Sales (P/S) ratio of 0.185 is a more appropriate valuation metric. This low P/S ratio suggests the market is valuing the company's revenue stream at a significant discount, reflecting concerns over its persistent losses and financial health. Data for a direct peer comparison using industry average valuation multiples is not available in the provided inputs.
PE
-2.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -15x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.0x
Enterprise Value Multiple
Investment Risk Disclosure
JetBlue's risk profile is elevated, dominated by financial and operational factors. The company's high debt-to-equity ratio of 4.84 and deeply negative free cash flow (-$1.02B TTM) create a precarious liquidity position, increasing vulnerability to economic downturns or rising interest rates. Operationally, the airline faces dual threats from external macro forces and internal execution, as highlighted by recent news concerning oil price volatility, potential airport disruptions from TSA staffing, and the company's own acknowledged 'winter breakdown.' Furthermore, the stock's high beta of 1.7 implies it will experience amplified volatility compared to the broader market, which is concerning given its current negative momentum and proximity to 52-week lows.
FAQ
The key risks are financial, operational, and market-related. Financially, the company has a high debt load (D/E of 4.84) and is burning cash (negative FCF of -$1.02B). Operationally, it faces volatile fuel costs, potential travel disruptions, and execution challenges, as recent news highlights. Market-wise, the stock has high beta (1.7) and has significantly underperformed the S&P 500 over the past year.
A reasonable 12-month forecast involves high uncertainty. The base case (50% probability) sees the stock trading between $4.50 and $5.50, reflecting its current distressed state. A successful turnaround could drive prices toward the $6.00-$6.50 range (25% probability), while further deterioration could see it retest its 52-week low near $3.34 (25% probability). Analyst consensus forecasts positive EPS of $1.52, which is a key upside variable.
JBLU appears statistically undervalued based on its sales, with a P/S ratio of only 0.185, which is very low. However, this 'undervaluation' is rational given its fundamental problems—negative earnings, poor returns on capital, and high debt. Therefore, it might be more accurate to say the stock is appropriately priced for its high level of risk rather than being a clear bargain.
JBLU is not a good stock to buy for most investors seeking stability or growth. While its low Price-to-Sales ratio of 0.185 suggests it is cheap, this discount reflects real dangers: a net loss of $177 million last quarter, a dangerously high debt-to-equity ratio of 4.84, and negative free cash flow. It is a speculative bet on a successful turnaround, not a fundamentally sound investment at this time.
JBLU is unsuitable for short-term investment due to its high volatility and lack of near-term positive catalysts. It could only be considered for a very long-term, high-risk portion of a portfolio by investors betting on a multi-year operational and financial turnaround. The company's deep-seated issues require a long time horizon to potentially resolve, making it a speculative long-term play, not a trade.